New NCI Director Plans Greater Support For Translational Research, Collaboration.
HHS Names Crawford FDA Deputy Commissioner; Williams Appointed Deputy For Oncology Division.
French Legion d’Honneur Bestowed On Hortobagyi.
Mammography Summit Planned For June In Milan.
Urgent Need For New Drugs To Treat Pre-Cancers: AACR.
Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.
FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.
American Home Products Changes Name To Wyeth.
Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Vinay Prasad to CBER employees: “It is not wise for FDA to further pollute the scientific literature with papers we cannot defend”
